State Street Corp Timber Pharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$0.28 - $0.41 $1,008 - $1,476
3,600 Added 3.32%
112,100 $43,000
Q2 2021

Aug 16, 2021
BUY
$1.06 - $2.25 $115,010 - $244,125
108,500 New
108,500 $132,000

About Timber Pharmaceuticals, Inc.

TMBR Quotes by TradingView
  • Ticker TMBR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,524,992
  • Description
  • Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...
More about TMBR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email